XML 23 R12.htm IDEA: XBRL DOCUMENT v3.5.0.2
(Notes)
6 Months Ended
Jul. 30, 2016
Share-based Compensation [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
Stock-Based Compensation - Stock Option Awards
Compensation is recognized for all stock-based compensation arrangements by the Company. Stock-based compensation expense for the second quarters of fiscal 2016 and fiscal 2015 related to stock option awards was $135,000 and $326,000, respectively. Stock-based compensation expense for the first six months of fiscal 2016 and fiscal 2015 related to stock option awards was $255,000 and $587,000, respectively. The Company has not recorded any income tax benefit from the exercise of stock options due to the uncertainty of realizing income tax benefits in the future.
As of July 30, 2016, the Company had one omnibus stock plan for which stock awards can be currently granted: the 2011 Omnibus Incentive Plan that provides for the issuance of up to 9,500,000 shares of the Company's stock. The 2004 Omnibus Stock Plan expired on June 22, 2014. No further awards may be made under the 2004 Omnibus Plan, but any award granted under the 2004 Omnibus Plan and outstanding on June 22, 2014 will remain outstanding in accordance with its terms. The 2001 Omnibus Stock Plan expired on June 21, 2011. No further awards may be made under the 2001 Omnibus Plan, but any award granted under the 2001 Omnibus Plan and outstanding on June 21, 2011 will remain outstanding in accordance with its terms. The 2011 plan is administered by the human resources and compensation committee of the board of directors and provides for awards for employees, directors and consultants. All employees and directors of the Company and its affiliates are eligible to receive awards under the plan. The types of awards that may be granted under this plan include restricted and unrestricted stock, restricted stock units, incentive and nonstatutory stock options, stock appreciation rights, performance units, and other stock-based awards. Incentive stock options may be granted to employees at such exercise prices as the human resources and compensation committee may determine but not less than 100% of the fair market value of the underlying stock as of the date of grant. No incentive stock option may be granted more than 10 years after the effective date of the respective plan's inception or be exercisable more than 10 years after the date of grant. Options granted to outside directors are nonstatutory stock options with an exercise price equal to 100% of the fair market value of the underlying stock as of the date of grant. With the exception of market-based options, options granted generally vest over three years in the case of employee stock options and vest immediately on the date of grant in the case of director options, and have contractual terms of 10 years from the date of grant.
The fair value of each time-based vesting option award is estimated on the date of grant using the Black-Scholes option pricing model that uses assumptions noted in the following table. Expected volatilities are based on the historical volatility of the Company's stock. Expected term is calculated using the simplified method taking into consideration the option's contractual life and vesting terms. The Company uses the simplified method in estimating its expected option term because it believes that historical exercise data cannot be accurately relied upon at this time to provide a reasonable basis for estimating an expected term due to the extreme volatility of its stock price and the resulting unpredictability of its stock option exercises. The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant. Expected dividend yields were not used in the fair value computations as the Company has never declared or paid dividends on its common stock and currently intends to retain earnings for use in operations.
 
Fiscal 2016
 
Fiscal 2015
Expected volatility
84%
 
76% - 82%
Expected term (in years)
5 - 6 years
 
5 - 6 years
Risk-free interest rate
1.6% - 1.7%
 
1.7% - 1.9%


A summary of the status of the Company’s stock option activity as of July 30, 2016 and changes during the six months then ended is as follows:
 
2011
Incentive
Stock
Option
Plan
 
Weighted
Average
Exercise
Price
 
2004
Incentive
Stock
Option
Plan
 
Weighted
Average
Exercise
Price
 
2001
Incentive
Stock
Option
Plan
 
Weighted
Average
Exercise
Price
Balance outstanding, January 30, 2016
1,555,000

 
$
4.30

 
670,000

 
$
6.18

 
399,000

 
$
7.78

Granted
1,126,000

 
$
1.21

 

 
$

 

 
$

Exercised

 
$

 

 
$

 

 
$

Forfeited or canceled
(609,000
)
 
$
4.73

 
(83,000
)
 
$
6.93

 
(47,000
)
 
$
11.19

Balance outstanding, July 30, 2016
2,072,000

 
$
2.49

 
587,000

 
$
6.07

 
352,000

 
$
7.33

Options exercisable at July 30, 2016
747,000

 
$
3.53

 
578,000

 
$
6.09

 
352,000

 
$
7.33


The following table summarizes information regarding stock options outstanding at July 30, 2016:
 
Options Outstanding
 
Options Vested or Expected to Vest
Option Type
Number of
Shares
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Life
(Years)
 
Aggregate
Intrinsic
Value
 
Number of
Shares
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Life
(Years)
 
Aggregate
Intrinsic
Value
2011 Incentive:
2,072,000

 
$
2.49

 
8.5
 
$
765,000

 
1,958,000

 
$
2.55

 
8.4
 
$
693,000

2004 Incentive:
587,000

 
$
6.07

 
2.9
 
$
4,200

 
586,000

 
$
6.07

 
2.9
 
$
4,200

2001 Incentive:
352,000

 
$
7.33

 
1.8
 
$

 
352,000

 
$
7.33

 
1.8
 
$


The weighted average grant-date fair value of options granted in the first six-months of fiscal 2016 and fiscal 2015 was $0.86 and $4.10, respectively. The total intrinsic value of options exercised during the first six-months of fiscal 2016 and fiscal 2015 was $0 and $1,441,000, respectively. As of July 30, 2016, total unrecognized compensation cost related to stock options was $948,000 and is expected to be recognized over a weighted average expected life of approximately 2.4 years.